WM
ADAP
WS Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-115,602
| Closed | -$124K | – | 46 |
|
|
2022
Q3 | $124K | Hold |
115,602
| – | – | 0.01% | 41 |
|
|
2022
Q2 | $197K | Hold |
115,602
| – | – | 0.02% | 49 |
|
|
2022
Q1 | $238K | Hold |
115,602
| – | – | 0.01% | 46 |
|
|
2021
Q4 | $434K | Hold |
115,602
| – | – | 0.03% | 44 |
|
|
2021
Q3 | $598K | Hold |
115,602
| – | – | 0.06% | 49 |
|
|
2021
Q2 | $492K | Hold |
115,602
| – | – | 0.05% | 57 |
|
|
2021
Q1 | $614K | Sell |
115,602
-5,941
| -5% | -$31.6K | 0.06% | 52 |
|
|
2020
Q4 | $655K | Hold |
121,543
| – | – | 0.07% | 41 |
|
|
2020
Q3 | $970K | Hold |
121,543
| – | – | 0.1% | 44 |
|
|
2020
Q2 | $1.22M | Sell |
121,543
-20,831
| -15% | -$209K | 0.15% | 40 |
|
|
2020
Q1 | $387K | Sell |
142,374
-7,133
| -5% | -$19.4K | 0.04% | 52 |
|
|
2019
Q4 | $179K | Hold |
149,507
| – | – | 0.02% | 51 |
|
|
2019
Q3 | $226K | Sell |
149,507
-16,440
| -10% | -$24.9K | 0.02% | 52 |
|
|
2019
Q2 | $667K | Sell |
165,947
-19,590
| -11% | -$78.7K | 0.04% | 53 |
|
|
2019
Q1 | $798K | Sell |
185,537
-24,922
| -12% | -$107K | 0.05% | 56 |
|
|
2018
Q4 | $1.21M | Sell |
210,459
-86,324
| -29% | -$496K | 0.06% | 63 |
|
|
2018
Q3 | $4.02M | Hold |
296,783
| – | – | 0.13% | 59 |
|
|
2018
Q2 | $3.52M | Buy |
+296,783
| New | +$3.52M | 0.1% | 57 |
|